Pasadena California

BioPharma

Why the complement system is set to shine

After a slow start, the race is on to inhibit key proteins and pathways within the complement system -- a biological cascade that is central to the innate immune system and many different diseases. As an added incentive, the one drug approved in this space is priced at $440,000 per year.